Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice.
Hui LiXinyu LiYu HaoChenghua WuYuhao FuNana SuHoulin ChenBinyu YingHaixing WangLihuang SuHaijian CaiQinlian HeMengsi CaiJunwei SunJing LinAaron ScottFanggao SmithXiaoying HuangShengwei JinPublished in: British journal of pharmacology (2022)
Maresin 1 improved abnormal pulmonary vascular remodelling and right ventricular dysfunction in PAH mice, targeting aberrant PASMC proliferation. This suggests Maresin 1 may have a potent therapeutic effect in vascular disease.